Intravitreal Bevacizumab for Management of Active Progressive Proliferative Diabetic Retinopathy (PDR)

Sponsor
Shahid Beheshti University of Medical Sciences
Study ID
NCT00370721
Phase
PHASE3
Status
Unknown

Conditions

Eligibility Criteria

Sex
ALL
Age
N/A - N/A
Healthy Volunteers
Not accepted

Interventions

Study Details

To evaluate the effect of intravitreal bevacizumab on the course of diabetic retinopathy in cases with the signs of active progressive PDR

Key Dates

First listed
Sep 1, 2006
Start date
Mar 31, 2006
Status verified
Jun 2008

Study Design

Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT

Arms

  • Experimental: I

Primary Outcome Measure

Regression of diabetic retinopathy

Central Contacts

Related Studies